In May 2023, when Novo reported that patients on the highest dose (50 mg) of oral semaglutide lost 15% of their weight after 64 weeks, the company said it planned to apply for approval by the end ...

Compounding pharmacies have been allowed to make generic semaglutide — the active ingredient in the blockbuster drugs — due to a short supply of the brand name medications that started in 2022.

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

I’m happy with the Ozempic. A. We are glad to hear of your good results. Many other people have also found semaglutide (Ozempic, Wegovy) effective for blood sugar control and weight loss.

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Since then, he has been covering stories in science and tech. Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but can be serious, a new study found ...

You should inject Ozempic (semaglutide) into your stomach, upper arm, or thigh. Your doctor will show you how and where to inject the drug. Read on to learn other instructions and precautions.

Patients with diabetes taking semaglutide had an absence of NAION risk at the 1-month, 3-month, 6-month, and 1-year time points after the index date. HealthDay News — For patients with diabetes ...

Oh-oh-oh Ozempic. Originally marketed for treating Type 2 diabetes, Ozempic—perhaps the most popular of the injectable medications called semaglutide that was FDA-approved in 2017—has become ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report published in the BMC Nephrology. Hyperkalemic Periodic Paralysis (HyperPP) is ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson. Novo Nordisk has filed for U.S. approval of an oral version of ...